关注
MATTHEW T HUEMAN
MATTHEW T HUEMAN
在 usuhs.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts
KA Hutcheson, BZ Atkins, MT Hueman, MB Hopkins, DD Glower, ...
Cell Transplantation 9 (3), 359-368, 2000
2872000
Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients
GE Peoples, JM Gurney, MT Hueman, MM Woll, GB Ryan, CE Storrer, ...
Journal of Clinical Oncology 23 (30), 7536-7545, 2005
2782005
Evolving treatment strategies for gallbladder cancer
MT Hueman, CM Vollmer, TM Pawlik
Annals of surgical oncology 16, 2101-2115, 2009
2342009
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: US Military Cancer Institute Clinical Trials …
GE Peoples, JP Holmes, MT Hueman, EA Mittendorf, A Amin, S Khoo, ...
Clinical Cancer Research 14 (3), 797-803, 2008
2172008
Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium
BZ Atkins, MT Hueman, JM Meuchel, MJ Cottman, KA Hutcheson, ...
The Journal of heart and lung transplantation 18 (12), 1173-1180, 1999
1851999
Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neu Peptide (AE37) Vaccine
JP Holmes, LC Benavides, JD Gates, MG Carmichael, MT Hueman, ...
Journal of Clinical Oncology 26 (20), 3426-3433, 2008
1552008
Cellular cardiomyoplasty improves diastolic properties of injured heart
BZ Atkins, MT Hueman, J Meuchel, KA Hutcheson, DD Glower, DA Taylor
Journal of Surgical Research 85 (2), 234-242, 1999
1451999
The impact of HER2/neu expression level on response to the E75 vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
LC Benavides, JD Gates, MG Carmichael, R Patel, JP Holmes, ...
Clinical Cancer Research 15 (8), 2895-2904, 2009
1362009
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology
ZA Dehqanzada, CE Storrer, MT Hueman, RJ Foley, KA Harris, YH Jama, ...
Oncology reports 17 (3), 687-694, 2007
1122007
Surgical diseases presenting in pregnancy
CS Dietrich III, CC Hill, M Hueman
Surgical Clinics of North America 88 (2), 403-419, 2008
1042008
Management of retroperitoneal sarcomas
MT Hueman, JM Herman, N Ahuja
Surgical clinics of north America 88 (3), 583-597, 2008
852008
Tumour location within the breast: Does tumour site have prognostic ability?
S Rummel, MT Hueman, N Costantino, CD Shriver, RE Ellsworth
Ecancermedicalscience 9, 2015
822015
Optimal dose and schedule of an HER‐2/neu (E75) peptide vaccine to prevent breast cancer recurrence From US Military Cancer Institute Clinical Trials Group …
JP Holmes, JD Gates, LC Benavides, MT Hueman, MG Carmichael, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
692008
Levels of circulating regulatory CD4+ CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine★
MT Hueman, A Stojadinovic, CE Storrer, RJ Foley, JM Gurney, CD Shriver, ...
Breast cancer research and treatment 98, 17-29, 2006
662006
Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients
MT Hueman, ZA Dehqanzada, TE Novak, JM Gurney, MM Woll, GB Ryan, ...
Clinical cancer research 11 (20), 7470-7479, 2005
632005
Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial
R Patil, GT Clifton, JP Holmes, A Amin, MG Carmichael, JD Gates, ...
Journal of the American College of Surgeons 210 (2), 140-147, 2010
612010
Management of gastrointestinal stromal tumors
MT Hueman, RD Schulick
Surgical Clinics of North America 88 (3), 599-614, 2008
572008
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients
ZA Dehqanzada, CE Storrer, MT Hueman, RJ Foley, KA Harris, YH Jama, ...
Clinical cancer research 12 (2), 478-486, 2006
552006
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine
MT Hueman, A Stojadinovic, CE Storrer, ZA Dehqanzada, JM Gurney, ...
Cancer Immunology, Immunotherapy 56, 135-146, 2007
492007
Nonsteroidal anti-inflammatory drugs may affect cytokine response and benefit healing of combat-related extremity wounds
FA Lisboa, MJ Bradley, MT Hueman, SA Schobel, BJ Gaucher, ...
Surgery 161 (4), 1164-1173, 2017
412017
系统目前无法执行此操作,请稍后再试。
文章 1–20